(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change
Exploring GLP-1s: The Rise of Weight Loss Medications Weight loss drugs like Mounjaro and Ozempic have surged in popularity over recent years
Rather than focusing on building a large supplement stack, many GLP-1 users benefit most from choosing simple, easy-to-maintain products that fit comfortably into their daily routine
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Thankfully, PlushCare offers around-the-clock email and phone support
LARA MALINS: So it's not to say that peptides need to be banned unilaterally, but it's the unregulated use of them, which is most concerning